Histotype
Liver
| Parameter | Information |
|---|---|
| Strain | C57BL/6 |
| Implant Type | Cells |
| Implant Location | SC, Axilla (High) |
| Time to Staging | 6 days |
| Time to 750mm³ | 19.6 days |
| Td | 5.4 days |
The above parameters are from one study. For further information on this cell line and other parameters, including different strains, vendors, implant type and location and/or standards of care, please contact us.
Tumor Line
Mouse
Ref #
9179
Syngenic Spotlight on Hepa 1-6
Learn more about this cell line in our scientific spotlights:
Hepatocellular carcinoma (HCC) affects over one million people globally and is currently the third leading cause of cancer related deaths in the world.[1] Worldwide, there are 800,000 new diagnoses and 700,000 patient deaths each year. The incidence of HCC is highest in Southeast Asia and Sub-Saharan Africa due to high prevalence of hepatitis B and C viruses which strongly predisposes one to develop chronic liver disease and subsequent HCC.[1,2] In the United States, there are expected to be 42,030 new diagnoses and 31,780 patient deaths in 2019.[2]
Murine Spotlight on Hepa 1-6
Learn more about this cell line in our scientific spotlights:
Hepatocellular carcinoma (HCC) is an aggressive malignancy which has gradually increased in incidence to affect one million people worldwide and is currently the third leading cause of cancer related deaths in the world.[1,2] The prevalence of HCC is highest in Asia and Africa due to high endemicity of hepatitis B and C viruses which strongly predispose to the development of chronic liver disease and subsequent HCC.[1]